Organ on Chip Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Organ on Chip Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Global Organ on Chip Market Analysis 2026

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx30.93%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Organ-on-Chip Market Organ Type Segment Analysis According to cognitive market research, Lung is the dominant category by leveraging the technology's potential to mimic physiological lung functions in vitro. These platforms offer realistic models for drug testing, disease modeling, and personalized medicine research, reducing reliance on animal testing and enhancing predictive accuracy. Lung-focused OoCs attract pharmaceutical companies and research institutions seeking to study respiratory diseases and test new therapies effectively. As demand grows for more reliable and ethical research methods, lung-centric OoCs drive innovation and adoption in the biotech and pharmaceutical sectors.

Liver Organ on Chip Market Analysis
XX
Liver Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Heart Organ on Chip Market Analysis
XX
Heart Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Lung Organ on Chip Market Analysis
XX
Lung Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Other Organ on Chip Market Analysis
XX
Other Market Size 2025
XX %
CAGR
Locked · Full data in paid report

Market size by (Illustrative, 2025)
Share distribution (2025)

Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

In May 2022, Emulate improved its intestinal organ-on-a-chip for inflammatory bowel disease research. (Source: https://www.fiercebiotech.com/medtech/emulate-launches-intestinal-organ-chip-exploring-inflammatory-bowel-disease)

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
BiomimX SRL••• ••• ••• •••
Elveflow••• ••• ••• •••
Emulate Inc.••• ••• ••• •••
Altis Biosystems••• ••• ••• •••
AxoSim••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global Organ-on-Chip market size was USD 0.3 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 30.93% from 2024 to 2031.

Introduction of the Organ-on-Chip Market

Organ-on-Chip markets include advancements in biomedical research, pharmaceutical testing, and personalized medicine. OOC technology replicates human organ functions on microchips, offering more accurate disease modeling and drug efficacy testing compared to traditional methods. This innovation reduces reliance on animal testing, accelerates drug development timelines, and enhances understanding of human physiology and disease mechanisms. The demand for OOC platforms is driven by their potential to provide personalized treatment strategies, improve therapeutic outcomes, and reduce healthcare costs. Additionally, collaborations between academia, pharmaceutical companies, and research institutions propel technological advancements and broaden the applications of OOC technology in drug discovery and toxicity testing, driving further market expansion.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Organ on Chip Market Analysis is witnessing significant growth in the near future.

In 2023, the Liver segment accounted for a notable share of the Organ on Chip Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

Organ on Chip Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers BiomimX SRL, Elveflow, Emulate Inc., Altis Biosystems, AxoSim and others are profiled in the report.
Segments include By Organ Type, By Application and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Organ on Chip Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
By Organ TypeLiver, Heart, Lung, Other
By ApplicationDrug Discovery, Toxicology Research, Other
By End UserPharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other
List of CompetitorsBiomimX SRL, Elveflow, Emulate Inc., Altis Biosystems, AxoSim

  • Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))

    • 1.1 Top Competitors Analysis
      • 1.1.1 Global Organ on Chip Market Analysis by Key Players
      • 1.1.2 Segment Market Analysis by Key Players
      • 1.1.3 Top Players Ranking 2024
      • 1.1.4 New Product Launch Analysis
      • 1.1.5 Industry Mergers and Acquisition Analysis
    • 1.2 Company Profile (Data Subject to Availability) Sample Format
      • 1.2.1 BiomimX SRL
        • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.1.2 Business Overview
        • 1.2.1.3 Financials (Subject to data availability)
        • 1.2.1.4 R&D Investment (Subject to data availability)
        • 1.2.1.5 Product Types Specification
        • 1.2.1.6 Business Strategy
        • 1.2.1.7 Recent Developments
        • 1.2.1.8 Management Change
        • 1.2.1.9 S.W.O.T Analysis
      • 1.2.2 Elveflow
        • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.2.2 Business Overview
        • 1.2.2.3 Financials (Subject to data availability)
        • 1.2.2.4 R&D Investment (Subject to data availability)
        • 1.2.2.5 Product Types Specification
        • 1.2.2.6 Business Strategy
        • 1.2.2.7 Recent Developments
        • 1.2.2.8 Management Change
        • 1.2.2.9 S.W.O.T Analysis
      • 1.2.3 Emulate Inc.
        • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.3.2 Business Overview
        • 1.2.3.3 Financials (Subject to data availability)
        • 1.2.3.4 R&D Investment (Subject to data availability)
        • 1.2.3.5 Product Types Specification
        • 1.2.3.6 Business Strategy
        • 1.2.3.7 Recent Developments
        • 1.2.3.8 Management Change
        • 1.2.3.9 S.W.O.T Analysis
      • 1.2.4 Altis Biosystems
        • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.4.2 Business Overview
        • 1.2.4.3 Financials (Subject to data availability)
        • 1.2.4.4 R&D Investment (Subject to data availability)
        • 1.2.4.5 Product Types Specification
        • 1.2.4.6 Business Strategy
        • 1.2.4.7 Recent Developments
        • 1.2.4.8 Management Change
        • 1.2.4.9 S.W.O.T Analysis
      • 1.2.5 AxoSim
        • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.5.2 Business Overview
        • 1.2.5.3 Financials (Subject to data availability)
        • 1.2.5.4 R&D Investment (Subject to data availability)
        • 1.2.5.5 Product Types Specification
        • 1.2.5.6 Business Strategy
        • 1.2.5.7 Recent Developments
        • 1.2.5.8 Management Change
        • 1.2.5.9 S.W.O.T Analysis

  • Chapter 2. Global Organ on Chip Market Analysis

    • 2.1 Global Organ on Chip Market Analysis
    • 2.2 Global Organ on Chip Market Analysis by Region
    • 2.3 Global Organ on Chip Market Analysis by By Organ Type
    • 2.4 Global Organ on Chip Market Analysis by By Application
    • 2.5 Global Organ on Chip Market Analysis by By End User
    • 2.6 Global Organ on Chip Market Analysis by Key Players

  • Chapter 3. North America Organ on Chip Market Analysis

    • 3.1 North America Organ on Chip Market Analysis
    • 3.2 North America Organ on Chip Market Analysis by Country
    • 3.3 North America Organ on Chip Market Analysis by By Organ Type
    • 3.4 North America Organ on Chip Market Analysis by By Application
    • 3.5 North America Organ on Chip Market Analysis by By End User
    • 3.6 North America Organ on Chip Market Analysis by Key Players

  • Chapter 4. Europe Organ on Chip Market Analysis

    • 4.1 Europe Organ on Chip Market Analysis
    • 4.2 Europe Organ on Chip Market Analysis by Country
    • 4.3 Europe Organ on Chip Market Analysis by By Organ Type
    • 4.4 Europe Organ on Chip Market Analysis by By Application
    • 4.5 Europe Organ on Chip Market Analysis by By End User
    • 4.6 Europe Organ on Chip Market Analysis by Key Players

  • Chapter 5. Asia Pacific Organ on Chip Market Analysis

    • 5.1 Asia Pacific Organ on Chip Market Analysis
    • 5.2 Asia Pacific Organ on Chip Market Analysis by Country
    • 5.3 Asia Pacific Organ on Chip Market Analysis by By Organ Type
    • 5.4 Asia Pacific Organ on Chip Market Analysis by By Application
    • 5.5 Asia Pacific Organ on Chip Market Analysis by By End User
    • 5.6 Asia Pacific Organ on Chip Market Analysis by Key Players

  • Chapter 6. South America Organ on Chip Market Analysis

    • 6.1 South America Organ on Chip Market Analysis
    • 6.2 South America Organ on Chip Market Analysis by Country
    • 6.3 South America Organ on Chip Market Analysis by By Organ Type
    • 6.4 South America Organ on Chip Market Analysis by By Application
    • 6.5 South America Organ on Chip Market Analysis by By End User
    • 6.6 South America Organ on Chip Market Analysis by Key Players

  • Chapter 7. Middle East Organ on Chip Market Analysis

    • 7.1 Middle East Organ on Chip Market Analysis
    • 7.2 Middle East Organ on Chip Market Analysis by Country
    • 7.3 Middle East Organ on Chip Market Analysis by By Organ Type
    • 7.4 Middle East Organ on Chip Market Analysis by By Application
    • 7.5 Middle East Organ on Chip Market Analysis by By End User
    • 7.6 Middle East Organ on Chip Market Analysis by Key Players

  • Chapter 8. Africa Organ on Chip Market Analysis

    • 8.1 Africa Organ on Chip Market Analysis
    • 8.2 Africa Organ on Chip Market Analysis by Country
    • 8.3 Africa Organ on Chip Market Analysis by By Organ Type
    • 8.4 Africa Organ on Chip Market Analysis by By Application
    • 8.5 Africa Organ on Chip Market Analysis by By End User
    • 8.6 Africa Organ on Chip Market Analysis by Key Players

  • Chapter 9. By Organ Type Analysis

    • 9.1 Liver
      • 9.1.1 Global Liver Market
      • 9.1.2 Global Liver Market by Region
    • 9.2 Heart
      • 9.2.1 Global Heart Market
      • 9.2.2 Global Heart Market by Region
    • 9.3 Lung
      • 9.3.1 Global Lung Market
      • 9.3.2 Global Lung Market by Region
    • 9.4 Other
      • 9.4.1 Global Other Market
      • 9.4.2 Global Other Market by Region

  • Chapter 10. By Application Analysis

    • 10.1 Drug Discovery
      • 10.1.1 Global Drug Discovery Market
      • 10.1.2 Global Drug Discovery Market by Region
    • 10.2 Toxicology Research
      • 10.2.1 Global Toxicology Research Market
      • 10.2.2 Global Toxicology Research Market by Region
    • 10.3 Other
      • 10.3.1 Global Other Market
      • 10.3.2 Global Other Market by Region

  • Chapter 11. By End User Analysis

    • 11.1 Pharmaceutical and Biotechnology Companies
      • 11.1.1 Global Pharmaceutical and Biotechnology Companies Market
      • 11.1.2 Global Pharmaceutical and Biotechnology Companies Market by Region
    • 11.2 Academic and Research Institutes
      • 11.2.1 Global Academic and Research Institutes Market
      • 11.2.2 Global Academic and Research Institutes Market by Region
    • 11.3 Other
      • 11.3.1 Global Other Market
      • 11.3.2 Global Other Market by Region

  • Chapter 12. Qualitative Analysis (Subject to Data Availability)

    • 12.1 Market Drivers
    • 12.2 Market Restraints
    • 12.3 Market Trends
    • 12.4 Market Opportunity
    • 12.5 Technological Road Map (Subject to Data Availability)
    • 12.6 Product Life Cycle (Subject to Data Availability)
    • 12.7 Customer and Buyer Behavior Analysis
      • 12.7.1 Digital Engagement, Customer Experience & Relationship Analysis
      • 12.7.2 Customer Buying Behavior & Purchase Decision Analysis
      • 12.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
      • 12.7.4 Pricing, Affordability & Value Perception Analysis
      • 12.7.5 Customer Segmentation & Demand Pattern Analysis
    • 12.8 PESTEL Analysis
      • 12.8.1 Political Factors
      • 12.8.2 Economic Factors
      • 12.8.3 Social Factors
      • 12.8.4 Technological Factors
      • 12.8.5 Legal Factors
      • 12.8.6 Environmental Factors
    • 12.9 Industrial Chain Analysis (Subject to Data Availability)
      • 12.9.1 Industry Chain Analysis
      • 12.9.2 Manufacturing Cost Analysis
      • 12.9.3 Supply Side Analysis
        • 12.9.3.1 Raw Material Analysis
        • 12.9.3.2 Raw Material Procurement Analysis
        • 12.9.3.3 Raw Material Price Trend Analysis
    • 12.10 Porter’s Five Forces Analysis
      • 12.10.1 Bargaining Power of Suppliers
      • 12.10.2 Bargaining Power of Buyers
      • 12.10.3 Threat of New Entrants
      • 12.10.4 Threat of Substitutes
      • 12.10.5 Degree of Competition
    • 12.11 Patent Analysis (Subject to Data Availability)
    • 12.12 ESG Analysis
    • 12.13 Geopolitical Outlook
      • 12.13.1 Global Power Realignment & Strategic Alliances
      • 12.13.2 Geopolitical Risk Landscape & Conflict Hotspots
      • 12.13.3 International Trade Relations & Market Access Environment
      • 12.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
      • 12.13.5 Supply Chain Resilience, Localization & Resource Nationalism
      • 12.13.6 Technology Sovereignty & Digital Geopolitics
      • 12.13.7 Strategic Implications for Investment, Growth & Market Entry
    • 12.14 AI & Market Transformation
      • 12.14.1 Competitive Landscape Disruption & Strategic Shifts
      • 12.14.2 AI-Driven Transformation of Industry Value Chain
      • 12.14.3 Evolution of Business Models & Revenue Streams
      • 12.14.4 AI-Driven Product, Service & Innovation Transformation
      • 12.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • Chapter 13. TOP 10 Country Analysis

    • 13.1 Country 1
    • 13.2 Country 2
    • 13.3 Country 3
    • 13.4 Country 4
    • 13.5 Country 5
    • 13.6 Country 6
    • 13.7 Country 7
    • 13.8 Country 8
    • 13.9 Country 9
    • 13.10 Country 10

  • Chapter 14. Research Findings

    • 14.1 Key Takeaways
    • 14.2 Analyst Point of View
    • 14.3 Assumptions and Acronyms

  • Chapter 15. Research Methodology and Sources

    • 15.1 Primary Data Collection
      • 15.1.1 Steps for Primary Data Collection
        • 15.1.1.1 Identification of KOL
      • 15.1.2 Backward Integration
      • 15.1.3 Forward Integration
      • 15.1.4 How Primary Research Help Us
      • 15.1.5 Modes of Primary Research
    • 15.2 Secondary Research
      • 15.2.1 How Secondary Research Help Us
      • 15.2.2 Sources of Secondary Research
    • 15.3 Data Validation
      • 15.3.1 Data Triangulation
    • 15.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Organ on Chip Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 5+
Forecast Accuracy (Historical) 94.2%
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Sources from the Medical Devices and Consumables Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Organ on Chip Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the organ on chip market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.